Skip to content
OpenCapital
Get started

BioCryst Pharmaceuticals BCRX Repayment Of Royalty Financing Liabilities, Principal

Repayment Of Royalty Financing Liabilities, Principal at other companies

BridgeBio Pharma logo
BridgeBio PharmaBBIO
$11.29M+7,742%
AnaptysBio, Inc. logo
AnaptysBio, Inc.ANAB
$12.81M-44.3%
Syndax Pharmaceuticals logo
Syndax PharmaceuticalsSNDX
$343.91M+3.7%
Rackspace Technology, Inc. logo
Rackspace Technology, Inc.RXT
$8.1M+15.7%
Bloom Energy logo
Bloom EnergyBE
$7.97M+198%
PENN Entertainment, Inc. logo
PENN Entertainment, Inc.PENN
$11.2M+4.7%

Other financials

Income statement

See full
Revenue$156.4M+7.5%
Gross profit$151.0M+7.1%
Operating income-$701.6M-3,405%
Net income-$721.8M-2,255,763%
EPS (diluted)-$2.98—

Balance sheet

See full
Cash & equivalents$173.4M+62.2%
Total debt$411.8M+24.7%
Total equity-$553.8M-22.6%
Total assets$465.1M-3.1%

Cash flow

See full
Operating cash flow-$61.8M-125%
CapEx$403.0K+182%
Free cash flow-$62.2M-125%

Valuation

See full
Market cap$2.37B+52.3%
Enterprise value$2.6B+46.7%
P/S2.7×-0.4×

Profitability

See full
Gross margin97.8%+0.8pp
Operating margin-43.1%-49.7pp
Net margin-51.7%-69.7pp
FCF margin35%—

Returns & leverage

See full
Return on equity-882.8%—
Debt / equity0.1×—
Current ratio1.9×-1.0×

Where this comes from

Reported directly by BioCryst Pharmaceuticals in its filing.

Tagged under the XBRL concept bcrx:RepaymentOfRoyaltyFinancingLiabilitiesPrincipal.

The official record: BioCryst Pharmaceuticals’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about BioCryst Pharmaceuticals's repayment of royalty financing liabilities, principal.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is BioCryst Pharmaceuticals's repayment of royalty financing liabilities, principal?
BioCryst Pharmaceuticals (BCRX) reported repayment of royalty financing liabilities, principal of $476K in Q1 2026.
What does repayment of royalty financing liabilities, principal mean?
This reflects the cash payments made to reduce the principal balance of financial obligations backed by future royalty streams from specific products or intellectual property. It represents a form of non-dilutive financing where the company monetizes future revenue to fund current operations or development. Tracking these payments is essential for assessing the company's long-term debt burden and the impact of royalty-based financing on future cash flow availability.